Tiantian Zhen

744 total citations
27 papers, 525 citations indexed

About

Tiantian Zhen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tiantian Zhen has authored 27 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Tiantian Zhen's work include Sarcoma Diagnosis and Treatment (9 papers), Cancer-related gene regulation (6 papers) and MicroRNA in disease regulation (4 papers). Tiantian Zhen is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Cancer-related gene regulation (6 papers) and MicroRNA in disease regulation (4 papers). Tiantian Zhen collaborates with scholars based in China. Tiantian Zhen's co-authors include Anjia Han, Huijuan Shi, Fenfen Zhang, Lili Kang, Yu Dong, Fenfen Zhang, Jiangtao Liang, Hui Li, Jing Duan and Ying-jie Liang and has published in prestigious journals such as PLoS ONE, European Journal of Cancer and The Journal of Pathology.

In The Last Decade

Tiantian Zhen

27 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tiantian Zhen China 12 328 259 131 113 68 27 525
Yu Yin China 13 329 1.0× 254 1.0× 106 0.8× 94 0.8× 39 0.6× 30 525
Jen-Wei Tsai Taiwan 13 283 0.9× 110 0.4× 184 1.4× 251 2.2× 75 1.1× 13 588
Xiujuan Han China 15 317 1.0× 158 0.6× 141 1.1× 53 0.5× 52 0.8× 35 525
Kelly M. Bailey United States 11 278 0.8× 115 0.4× 179 1.4× 137 1.2× 47 0.7× 30 552
Sylvie Rothhut France 12 422 1.3× 159 0.6× 150 1.1× 144 1.3× 43 0.6× 14 548
Semra Demokan Türkiye 16 684 2.1× 271 1.0× 203 1.5× 74 0.7× 108 1.6× 33 873
Xianmin Bu China 16 261 0.8× 147 0.6× 146 1.1× 88 0.8× 38 0.6× 39 545
Jianhui Qu China 11 234 0.7× 166 0.6× 166 1.3× 135 1.2× 60 0.9× 27 735
Kshitij S. Arora United States 13 284 0.9× 158 0.6× 254 1.9× 113 1.0× 41 0.6× 37 684
Nina Waldburger Germany 13 201 0.6× 119 0.5× 149 1.1× 94 0.8× 34 0.5× 19 456

Countries citing papers authored by Tiantian Zhen

Since Specialization
Citations

This map shows the geographic impact of Tiantian Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiantian Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiantian Zhen more than expected).

Fields of papers citing papers by Tiantian Zhen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiantian Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiantian Zhen. The network helps show where Tiantian Zhen may publish in the future.

Co-authorship network of co-authors of Tiantian Zhen

This figure shows the co-authorship network connecting the top 25 collaborators of Tiantian Zhen. A scholar is included among the top collaborators of Tiantian Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiantian Zhen. Tiantian Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Yu, Fenfen Zhang, Tiantian Zhen, et al.. (2024). Claudin18.2 expression and its clinicopathological feature in adenocarcinoma from various parts. Journal of Clinical Pathology. 78(12). 815–821. 3 indexed citations
2.
Huang, C. Y., Jia Luo, Zhen Shan, et al.. (2024). The value of the improved percutaneous and intravenous contrast-enhanced ultrasound diagnostic classification in sentinel lymph nodes of breast cancer. Quantitative Imaging in Medicine and Surgery. 14(3). 2391–2404. 2 indexed citations
3.
Liu, Yiqing, et al.. (2023). AI-Powered Segmentation of Invasive Carcinoma Regions in Breast Cancer Immunohistochemical Whole-Slide Images. Cancers. 16(1). 167–167. 7 indexed citations
4.
Zhen, Tiantian, et al.. (2021). Malignant adenomyoepithelioma of the breast: Two case reports and review of the literature. World Journal of Clinical Cases. 9(31). 9549–9556. 3 indexed citations
5.
Gao, Huabin, Lin Chen, Hui Li, et al.. (2021). A Prognosis Marker SLC2A3 Correlates With EMT and Immune Signature in Colorectal Cancer. Frontiers in Oncology. 11. 638099–638099. 34 indexed citations
6.
Yang, Yang, Huabin Gao, Tiantian Zhen, et al.. (2020). Hemangioblastoma: clinicopathologic study of 42 cases with emphasis on TFE3 expression.. PubMed. 12(8). 4498–4510. 3 indexed citations
7.
Duan, Jing, Tiantian Zhen, Jiangtao Liang, et al.. (2018). The clinicopathological significance of ZNF10 in invasive ductal carcinoma of the breast.. PubMed. 11(6). 2968–2979. 6 indexed citations
8.
Duan, Jing, Lin Chen, Huabin Gao, et al.. (2018). GALNT6 suppresses progression of colorectal cancer.. PubMed. 8(12). 2419–2435. 16 indexed citations
9.
Liang, Jiangtao, Jianming Tang, Huijuan Shi, et al.. (2017). miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway. Oncotarget. 8(47). 82991–83008. 55 indexed citations
10.
Tang, Jianming, Huijuan Shi, Hui Li, et al.. (2016). The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma. Tumor Biology. 37(8). 10287–10301. 5 indexed citations
11.
Chen, Yanyang, Huijuan Shi, Hui Li, Tiantian Zhen, & Anjia Han. (2015). Clinicopathological features of inflammatory pseudotumour‐like follicular dendritic cell tumour of the abdomen. Histopathology. 68(6). 858–865. 34 indexed citations
12.
Shi, Huijuan, Hui Li, Tiantian Zhen, et al.. (2015). Clinicopathological features of angiomatoid fibrous histiocytoma: a series of 21 cases with variant morphology.. PubMed. 8(1). 772–8. 27 indexed citations
13.
Lian, Jiayan, Jianming Tang, Huijuan Shi, et al.. (2015). Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer. Oncotarget. 6(30). 29357–29374. 21 indexed citations
14.
Shi, Huijuan, et al.. (2015). Yolk sac tumor of the external auditory canal: a case report and literature review.. PubMed. 8(11). 15001–6. 1 indexed citations
15.
Kang, Lili, Fenfen Zhang, Hui Li, et al.. (2014). Retinoid X Receptor-α Expression Suppression and its Promoter Methylation Associates with β-catenin Expression in Colorectal Cancer. 2(6). 153–160. 1 indexed citations
16.
Li, Hui, Tiantian Zhen, Huijuan Shi, et al.. (2014). Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. European Journal of Cancer. 50(6). 1207–1221. 59 indexed citations
17.
Shi, Huijuan, Qinghua Cao, Hui Li, et al.. (2014). Malignant perivascular epithelioid cell tumor of the kidney with rare pulmonary and ileum metastases.. PubMed. 7(9). 6357–63. 10 indexed citations
18.
Shi, Huijuan, Hui Li, Tiantian Zhen, Fenfen Zhang, & Anjia Han. (2014). Hemangioblastoma of pelvic cavity: report of a case and review of literature.. PubMed. 7(10). 7054–8. 5 indexed citations
19.
Li, Hui, Huijuan Shi, Fenfen Zhang, et al.. (2013). MACC1 Down-Regulation Inhibits Proliferation and Tumourigenicity of Nasopharyngeal Carcinoma Cells through Akt/β-Catenin Signaling Pathway. PLoS ONE. 8(4). e60821–e60821. 51 indexed citations
20.
Yang, Yang, Hui Li, Fenfen Zhang, et al.. (2013). Clinical and biological significance of hepatoma‐derived growth factor in Ewing's sarcoma. The Journal of Pathology. 231(3). 323–334. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026